ORIC PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.07 USD | +5.22% |
|
-12.19% | -12.28% |
Chart calendar ORIC Pharmaceuticals, Inc.
5d6fb1fd6850.S65Cpl540cKvVmKQFMI912zaYhOR3N0Viqqw2Bomr-4.CukK8h8T4ZDXPjT3WppMkjitU1L8iJUn4OfXq0h2w5wfxhfRGjKHneI5FQ~6ff147e74cf7910595228db113aab8f5
Upcoming events on ORIC Pharmaceuticals, Inc.
Past events on ORIC Pharmaceuticals, Inc.
| 17/04/2024 10:00 pm | Stifel Virtual Targeted Oncology Days Conference |
| 12/04/2024 01:15 am | Needham Healthcare Conference |
| 10/04/2024 03:00 am | American Association for Cancer Research Meeting - Abstract Number: 6856 |
| 08/04/2024 01:30 am | American Association for Cancer Research Meeting - Lori Friedman, Ph.D. |
| 07/04/2024 11:00 pm | American Association for Cancer Research Meeting - Abstract Number: 594 |
| 13/03/2024 05:30 pm | Leerink Partners Global Biopharma Conference |
| 12/03/2024 01:35 am | Q4 2023 Earnings Release |
| 22/02/2024 01:30 am | Citi Oncology Leadership Summit |
| 14/02/2024 10:30 pm | Oppenheimer Healthcare Life Sciences Conference |
| 07/02/2024 08:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 10/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No:4761 |
| 12/12/2023 03:00 am | American Society of Hematology Meeting |
| 28/11/2023 08:55 pm | Evercore ISI HealthCONx Conference |
| 16/11/2023 03:30 pm | Jefferies London Healthcare Conference |
| 07/11/2023 02:40 am | Q3 2023 Earnings Release |
| 23/10/2023 12:30 pm | European Society for Medical Oncology Congress - Poster No. 1345P |
| 23/10/2023 12:30 pm | European Society for Medical Oncology Congress - Poster No. 1333P |
| 21/10/2023 06:30 pm | European Society for Medical Oncology Congress |
| 28/09/2023 05:30 pm | Cantor Global Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -73,2 -59,0 -24.09% | -78,0 -74,5 -4.72% | -90,8 -87,9 -3.25% | -110 -106 -3.63% | -127 |
|
EBIT Million USD | Released Forecast Spread | -28,6 | -74,2 -57,1 -29.91% | -78,9 -78,6 -0.4% | -91,8 -90,0 -1.98% | -111 -108 -2.39% | -132 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -73,7 -56,3 -30.93% | -78,7 -77,1 -2.13% | -89,1 -90,0 1.02% | -101 -99,3 -1.38% | -123 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -73,7 -58,4 -26.27% | -78,7 -78,7 0.03% | -89,1 -89,9 0.91% | -101 -99,3 -1.37% | -123 |
|
EPS USD | Released Forecast Spread | 0,00 | -3,36 -3,22 -4.31% | -2,07 -2,08 0.26% | -2,25 -2,25 -0.17% | -1,96 -1,95 -0.67% | -1,83 |
| Announcement Date | 28/02/20 | 23/03/21 | 21/03/22 | 16/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -21,9 -22,0 0.58% | -25,4 -23,0 -10.54% | -24,7 -26,0 4.87% | -28,4 -25,0 -13.7% | -31,2 -28,2 -10.36% | -31,0 | -31,8 | -32,1 | -32,4 | |||||
|
EBIT Million USD | Released Forecast Spread | -22,8 -22,1 -3.27% | -23,3 -22,6 -3.07% | -20,7 -23,8 12.94% | -25,7 -21,9 -17.08% | -22,1 -22,3 0.64% | -25,7 -23,2 -10.68% | -25,0 -26,6 5.97% | -28,7 -26,3 -9.14% | -31,4 -29,1 -7.82% | -31,6 | -32,3 | -33,5 | -34,1 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,8 -21,1 -7.73% | -23,2 -22,2 -4.33% | -20,3 -24,1 15.7% | -24,8 -21,9 -13.3% | -20,8 -22,5 7.18% | -23,9 -23,1 -3.55% | -22,9 -26,1 12.24% | -25,5 -24,7 -3.04% | -28,3 -27,0 -4.75% | -29,3 | -29,7 | -31,3 | -32,3 | |
|
Net income Million USD | Released Forecast Spread | -22,8 -21,8 -4.5% | -23,2 -22,4 -3.39% | -20,3 -23,7 14.42% | -24,8 -21,9 -13.3% | -20,8 -22,5 7.18% | -23,9 -23,1 -3.55% | -22,9 -26,1 12.24% | -25,5 -24,7 -3.04% | -28,3 -27,0 -4.75% | -29,3 | -29,7 | -31,3 | -32,3 | |
|
EPS USD | Released Forecast Spread | -0,58 -0,58 -0.24% | -0,59 -0,57 -2.96% | -0,51 -0,60 15.19% | -0,63 -0,56 -13.28% | -0,52 -0,54 3.31% | -0,53 -0,55 3.69% | -0,50 -0,58 13.51% | -0,44 -0,47 5.47% | -0,49 -0,48 -2.37% | -0,44 | -0,43 | -0,45 | -0,47 | |
| Announcement Date | 21/03/22 | 09/05/22 | 11/08/22 | 07/11/22 | 16/03/23 | 08/05/23 | 10/08/23 | 06/11/23 | 11/03/24 | - | - | - | - | - |
More events
Past sector events for ORIC Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORIC Stock
- Calendar ORIC Pharmaceuticals, Inc.
